Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Clinical Value of Asymmetrical Dimethylarginine Detection in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.

Liu J, Fu Q, Jiang L, Wang Y.

Cardiol Res Pract. 2019 Aug 14;2019:3741909. doi: 10.1155/2019/3741909. eCollection 2019.

2.

Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension.

Dimitroulas T, Giannakoulas G, Sfetsios T, Karvounis H, Dimitroula H, Koliakos G, Settas L.

Rheumatology (Oxford). 2008 Nov;47(11):1682-5. doi: 10.1093/rheumatology/ken346. Epub 2008 Aug 27.

PMID:
18753191
3.

The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.

Thakkar V, Stevens W, Prior D, Rabusa C, Sahhar J, Walker JG, Roddy J, Lester S, Rischmueller M, Zochling J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):129-136. Epub 2016 May 23.

PMID:
27214686
4.

[Clinical value of ADMA in patients with pulmonary arterial hypertension combination with congenital heart disease].

Chen P, Huang Y, Fang Z, Hu X, Shen X, Zhou S.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Jan 28;42(1):35-40. doi: 10.11817/j.issn.1672-7347.2017.01.006. Chinese.

5.

Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study.

Nakamura H, Kato M, Nakaya T, Kono M, Tanimura S, Sato T, Fujieda Y, Oku K, Ohira H, Bohgaki T, Yasuda S, Tsujino I, Nishimura M, Atsumi T.

Medicine (Baltimore). 2017 Oct;96(43):e8349. doi: 10.1097/MD.0000000000008349.

6.

Asymmetric Dimethyl-L-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease.

Fang ZF, Huang YY, Tang L, Hu XQ, Shen XQ, Tang JJ, Zhou SH.

Pediatr Cardiol. 2015 Jun;36(5):1062-9. doi: 10.1007/s00246-015-1127-3. Epub 2015 Mar 4.

PMID:
25737007
7.

Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection.

Parikh RV, Scherzer R, Nitta EM, Leone A, Hur S, Mistry V, Macgregor JS, Martin JN, Deeks SG, Ganz P, Hsue PY.

AIDS. 2014 Feb 20;28(4):511-9. doi: 10.1097/QAD.0000000000000124.

8.

Oxidative stress and nitric oxide signaling related biomarkers in patients with pulmonary hypertension: a case control study.

Zhang S, Yang T, Xu X, Wang M, Zhong L, Yang Y, Zhai Z, Xiao F, Wang C.

BMC Pulm Med. 2015 May 2;15:50. doi: 10.1186/s12890-015-0045-8.

9.

Screening for connective tissue disease in pulmonary arterial hypertension.

Pagán RJ, Lee AS, Austin CO, Burger CD.

South Med J. 2014 Oct;107(10):666-9. doi: 10.14423/SMJ.0000000000000175.

PMID:
25279875
10.

Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.

Langleben D, Orfanos SE, Giovinazzo M, Hirsch A, Baron M, Senécal JL, Armaganidis A, Catravas JD.

Arthritis Rheum. 2008 Apr;58(4):1156-64. doi: 10.1002/art.23405.

11.

[Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension].

Zhao Q, Liu Z, Ma X, Zhao Z, Luo Q, Gu Q, Xiong C, Zhang H, Wang Y.

Zhonghua Yi Xue Za Zhi. 2015 Nov 24;95(44):3598-601. Chinese.

PMID:
26813372
12.

[Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].

Xing Y, Song HM, Wu XY, He YY, Wei M.

Zhonghua Er Ke Za Zhi. 2008 Nov;46(11):822-6. Chinese.

PMID:
19099898
13.

Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension.

Tamura Y, Ono T, Kuwana M, Inoue K, Takei M, Yamamoto T, Kawakami T, Fujita J, Kataoka M, Kimura K, Sano M, Daida H, Satoh T, Fukuda K.

PLoS One. 2012;7(9):e45834. doi: 10.1371/journal.pone.0045834. Epub 2012 Sep 21.

14.

[Value of four-dimensional echocardiography combined with speckle tracking technique on the assessment of right heart function and prognosis in patients with pulmonary arterial hypertension].

Zhang XM, Zhuang Q, Yang MH, Wang W, Zheng Y, Qiao ZQ, Shen JY, Shen XD.

Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Dec 24;46(12):965-971. doi: 10.3760/cma.j.issn.0253-3758.2018.12.007. Chinese.

PMID:
30572401
15.

Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.

Bai Y, Yang J, Liu J, Ning H, Zhang R.

Int J Cardiovasc Imaging. 2019 Sep;35(9):1637-1649. doi: 10.1007/s10554-019-01613-w. Epub 2019 Apr 29.

PMID:
31037473
16.

Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders.

Bellan M, Giubertoni A, Piccinino C, Dimagli A, Grimoldi F, Sguazzotti M, Burlone ME, Smirne C, Sola D, Marino P, Pirisi M, Sainaghi PP.

Dis Markers. 2019 Jun 2;2019:4981982. doi: 10.1155/2019/4981982. eCollection 2019.

17.

Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease.

Sanli C, Oguz D, Olgunturk R, Tunaoglu FS, Kula S, Pasaoglu H, Gulbahar O, Cevik A.

Pediatr Cardiol. 2012 Dec;33(8):1323-31. doi: 10.1007/s00246-012-0321-9. Epub 2012 Apr 21.

PMID:
22526220
18.

Anti-endothelial cell antibodies in connective tissue diseases associated with pulmonary arterial hypertension.

Liu XD, Guo SY, Yang LL, Zhang XL, Fu WY, Wang XF.

J Thorac Dis. 2014 May;6(5):497-502. doi: 10.3978/j.issn.2072-1439.2014.03.27.

19.

Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.

Gladue H, Altorok N, Townsend W, McLaughlin V, Khanna D.

Semin Arthritis Rheum. 2014 Feb;43(4):536-41. doi: 10.1016/j.semarthrit.2013.08.002. Epub 2013 Sep 5. Review.

20.

Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction.

Sandqvist A, Schneede J, Kylhammar D, Henrohn D, Lundgren J, Hedeland M, Bondesson U, Rådegran G, Wikström G.

Heart Vessels. 2018 Mar;33(3):255-263. doi: 10.1007/s00380-017-1055-7. Epub 2017 Oct 3.

Supplemental Content

Support Center